These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 13269404)
1. An in vitro study of antileukemic serum. THOMPSON JS Blood; 1955 Dec; 10(12):1228-35. PubMed ID: 13269404 [No Abstract] [Full Text] [Related]
2. The production of anti-human leukemic serum in rabbits. GARB S; STEIN AA; SIMS G J Immunol; 1962 Feb; 88():142-52. PubMed ID: 13896735 [No Abstract] [Full Text] [Related]
3. Passive immunity against four mouse leukoses by means of isoimmune sera. AMOS DB; DAY ED Ann N Y Acad Sci; 1957 Mar; 64(5):851-8. PubMed ID: 13411924 [No Abstract] [Full Text] [Related]
4. IN VIVO AND IN VITRO ACTIVITY OF TOLERANT ANTI-LEUKAEMIA SERUM. LEVI E Nature; 1964 May; 202():816-8. PubMed ID: 14187641 [No Abstract] [Full Text] [Related]
5. [On the mode of action of heterologous antileukemic sera. Growth of syngeneically transplanted leukemia cells on serum treated neonatally thymectomized mice (author's transl)]. Milleck J; Petro J; Madri M; Broen B; Eckert R Arch Geschwulstforsch; 1975; 45(6):541-4. PubMed ID: 1225257 [TBL] [Abstract][Full Text] [Related]
6. [Experimental study on antileukemic sera. II. The effect of leukemic autoplasma on antiserum cytotoxic reactions]. Yang QE; Zhang A Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):87-9. PubMed ID: 6407736 [No Abstract] [Full Text] [Related]
7. Specific antileukemic activity of heterologous immune sera animals pretreated after birth with normal human antigens. HOLECKOVA E; SEKLA B; CUMLIVSKI B; KOUT M; JANELE J Acta Unio Int Contra Cancrum; 1963; 19():107-9. PubMed ID: 13961285 [No Abstract] [Full Text] [Related]
9. NEUTRALIZATION IN VITRO OF MOUSE LEUKEMIA VIRUS BY SPECIFIC IMMUNE SERUM. IMPORTANCE OF VIRUS TITRATION. GROSS L Proc Soc Exp Biol Med; 1965 Jun; 119():420-7. PubMed ID: 14330895 [No Abstract] [Full Text] [Related]
10. ACTION OF ISOIMMUNE SERUM ON PERITONEAL CELLS IN VITRO. BENNETT B; LICURSI P Proc Soc Exp Biol Med; 1964 Jun; 116():404-9. PubMed ID: 14189151 [No Abstract] [Full Text] [Related]
11. Immunological relationships of a filterable agent causing a leukemia in adult mice. I. The neutralization of infectivity by specific antiserum. FRIEND C J Exp Med; 1959 Feb; 109(2):217-28. PubMed ID: 13620850 [TBL] [Abstract][Full Text] [Related]
12. ON SPLEEN-ANTIGENS REDUCTION IN HUMAN MYELOID LEUKEMIA. VULCHANOV VH C R Acad Bulg Sci; 1964; 17():769-72. PubMed ID: 14207684 [No Abstract] [Full Text] [Related]
14. [Studies on specific leukocytic antigens and essay of application of specific serum in leukemia]. LILLE-SZYSZKOWICZ I Sang; 1956; 27(5):382-5. PubMed ID: 13390749 [No Abstract] [Full Text] [Related]
15. Immunotherapy of leukemia: the use of different classes of immune lymphocytes. Alexander P Cancer Res; 1967 Dec; 27(12):2521-6. PubMed ID: 6082294 [No Abstract] [Full Text] [Related]
16. [SPECIFIC CYTOTOXIC EFFECT OF ANTI-SCHWANN CELL SERUM IN VITRO]. PALACIOS O; HIERONYMI B Arch Histol Norm Patol; 1963; 8():269-77. PubMed ID: 14107681 [No Abstract] [Full Text] [Related]
17. Immunofluorescent studies of human leukemic cells with antiserum to a murine leukemic virus (Rauscher strain). Ioannides AK; Rosner F; Brenner M; Lee SL Blood; 1968 Mar; 31(3):381-7. PubMed ID: 4966600 [No Abstract] [Full Text] [Related]
18. TYPING OF MOUSE LEUKAEMIAS BY SEROLOGICAL METHODS. OLD LJ; BOYSE EA; STOCKERT E Nature; 1964 Feb; 201():777-9. PubMed ID: 14161198 [No Abstract] [Full Text] [Related]
19. SPECIFICITY OF ISOANTISERA AGAINST LEUKAEMIC AND THYMIC LYMPHOCYTES. REIF AE; ALLEN JM Nature; 1963 Dec; 200():1332-3. PubMed ID: 14098493 [No Abstract] [Full Text] [Related]
20. Further research about the haemagglutination of serum-fractions from leukaemic subjects. Gomirato Sandrucci M; Nigro N; Benso L; Bonenti C; Papa G Panminerva Med; 1967; 9(7):269-72. PubMed ID: 4864446 [No Abstract] [Full Text] [Related] [Next] [New Search]